GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celon Pharma SA (FRA:8RP) » Definitions » FCF Yield %

Celon Pharma (FRA:8RP) FCF Yield % : -2.47 (As of Apr. 15, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Celon Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Celon Pharma's Trailing 12-Month Free Cash Flow is €-7.96 Mil, and Market Cap is €311.38 Mil. Therefore, Celon Pharma's FCF Yield % for today is -2.47%.

The historical rank and industry rank for Celon Pharma's FCF Yield % or its related term are showing as below:

FRA:8RP' s FCF Yield % Range Over the Past 10 Years
Min: -7.06   Med: -2.01   Max: 0.47
Current: -2.47


During the past 9 years, the highest FCF Yield % of Celon Pharma was 0.47%. The lowest was -7.06%. And the median was -2.01%.

FRA:8RP's FCF Yield % is ranked worse than
63.4% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 0.16 vs FRA:8RP: -2.47

Celon Pharma's FCF Margin % for the quarter that ended in Sep. 2024 was -37.82%.


Celon Pharma FCF Yield % Historical Data

The historical data trend for Celon Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celon Pharma FCF Yield % Chart

Celon Pharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only - - 0.20 -6.22 -5.66

Celon Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.30 0.45 -3.45 -4.57 -5.72

Competitive Comparison of Celon Pharma's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Celon Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Celon Pharma's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Celon Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Celon Pharma's FCF Yield % falls into.


;
;

Celon Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Celon Pharma's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-10.046 / 177.423075
=-5.66%

Celon Pharma's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-4.688 * 4 / 327.98913
=-5.72%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Celon Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Celon Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Celon Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Celon Pharma Business Description

Traded in Other Exchanges
Address
Ogrodowa 2A, Kielpin, Lomianki, POL, 05-092
Celon Pharma SA is a Poland based company engages in the research of therapeutic solutions and development, production, distribution, and marketing of specialized generic products. It invests in the development of innovative pharmaceuticals with potential applications in the treatment of cancer, neurological diseases, diabetes and other metabolic disorders. Its products portfolio comprises pills, such as Aromek, Bosentan Celon, Donepex, Ketrel, Lazivir, and Valzek, as well as inhalation powder.

Celon Pharma Headlines

No Headlines